REG - Susquehanna Ire. Ltd Shire plc Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical CoAnnouncement

28/12/2018 09:45

RNS Number : 7011L
Susquehanna Ireland Ltd
28 December 2018
 


FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Full name of discloser:


Susquehanna International Holdings LLC ("SIHLLC")




(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.


n/a




(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Ltd




(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:


n/a




(e) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


27/12/2018




(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES -Shire Plc



 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



Class of relevant security:
 


Ordinary Stock ISIN: JP3463000004
ISIN: US8740602052
 




 
 


Interests


Short positions








Number


%


Number


%




(1) Relevant securities owned and/or controlled:


1,000






0








(2) Cash-settled derivatives:
 


0






(4,697,800)
 


-0.60%




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:




















 
     TOTAL:


1,000






(4,697,800)
 


-0.60%



 
 
 
 
 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 

 (b)       Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:








Details, including nature of the rights concerned and relevant percentages:







 
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


Purchase/sale
 


Number of securities


Price per unit (JPY)




ORD


SALE


-100


3846




ORD


SALE


-1500


3835




ORD


PURCHASE


100


3848




ORD


PURCHASE


1000


3849




ORD


PURCHASE


2400


3850




ORD


SALE


-300


3841




ORD


SALE


-1100


3840




ORD


SALE


-900


3837




ORD


SALE


-900


3836




ORD


SALE


-300


3829




ORD


PURCHASE


100


3845




ORD


PURCHASE


200


3840




ORD


PURCHASE


200


3841




ORD


SALE


-500


3841




ORD


PURCHASE


100


3844




ORD


SALE


-100


3840




ORD


PURCHASE


100


3781




ORD


SALE


-100


3778




ORD


PURCHASE


100


3762




ORD


SALE


-100


3762




ORD


PURCHASE


600


3757




ORD


PURCHASE


100


3761




ORD


PURCHASE


900


3771




ORD


PURCHASE


300


3775




ORD


PURCHASE


100


3782.5




ORD


SALE


-100


3782




ORD


SALE


-500


3783




ORD


SALE


-900


3781




ORD


SALE


-500


3779




ORD


PURCHASE


400


3814




ORD


SALE


-400


3815




ORD


PURCHASE


200


3819.5




ORD


SALE


-100


3817




ORD


SALE


-100


3818




ORD


PURCHASE


100


3805




ORD


PURCHASE


400


3806




ORD


SALE


-500


3807




ORD


PURCHASE


200


3807.5




ORD


SALE


-200


3810




ORD


PURCHASE


100


3810




ORD


SALE


-100


3809




ORD


PURCHASE


4600


3820




ORD


PURCHASE


800


3823




ORD


PURCHASE


400


3824




ORD


PURCHASE


2000


3826




ORD


PURCHASE


200


3825.5




ORD


PURCHASE


200


3825.5




ORD


SALE


-300


3824




ORD


SALE


-1600


3823




ORD


SALE


-2900


3824




ORD


SALE


-3400


3823




ORD


PURCHASE


100


3834




ORD


PURCHASE


100


3838




ORD


PURCHASE


100


3841.5




ORD


SALE


-100


3842




ORD


PURCHASE


200


3848




ORD


PURCHASE


1700


3849




ORD


PURCHASE


200


3849




ORD


PURCHASE


700


3851




ORD


SALE


-100


3850




ORD


SALE


-1000


3847




ORD


SALE


-600


3845




ORD


SALE


-700


3844




ORD


SALE


-100


3844




ORD


SALE


-500


3843




ORD


PURCHASE


200


3853.5




ORD


SALE


-100


3855




ORD


SALE


-100


3855




ORD


PURCHASE


100


3858.5




ORD


SALE


-100


3859




ORD


PURCHASE


200


3862




ORD


SALE


-100


3860




ORD


SALE


-100


3858




ORD


PURCHASE


100


3860




ORD


PURCHASE


100


3860




ORD


SALE


-200


3860




ORD


PURCHASE


700


3800




ORD


PURCHASE


100


3800




ORD


PURCHASE


200


3792





















 
 
 
 
 
 
 
 
(b)        Cash-settled derivative transactions
 



Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit




CFD (on ordinary shares)


CFD


Increasing a short position


150,000
 


3814.6213
JPY



 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit





































 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit




















 
 



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)








 
 











 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


NO



 
 



Date of disclosure:


28/12/2018




Contact name:


Diana Taraseviciute /Olive Fogarty




Telephone number*:


353-1-8028419/8059



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETPGGMWPUPRUBR